Friday, Jun 18, 2021
Focus on the big picture

Biogen CEO Sees New Chapter in Fight Against Alzheimer's

Bloomberg, 08 Jun 2021
Jun.07 -- Biogen CEO Michel Vounatsos discusses the implications of the FDA's approval of the company's controversial Alzheimer's disease therapy, which will ...
Related Articles